LTAS
NBIX icon

Linden Thomas Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History

Linden Thomas Advisory Services’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
18,676
+11,215
+150% +$1.66M 0.25% 115
2026
Q1 		$983K Buy
7,461
+650
+10% +$86.2K 0.09% 319
2025
Q4 		$966K Sell
6,811
-34
-0.5% -$4.93K 0.1% 304
2025
Q3 		$961K Buy
6,845
+146
+2% +$19.8K 0.1% 304
2025
Q2 		$842K Buy
6,699
+96
+1% +$11K 0.09% 322
2025
Q1 		$730K Buy
6,603
+253
+4% +$32K 0.09% 327
2024
Q4 		$867K Buy
6,350
+289
+5% +$35.7K 0.11% 307
2024
Q3 		$698K Buy
6,061
+265
+5% +$36.3K 0.1% 329
2024
Q2 		$798K Sell
5,796
-972
-14% -$133K 0.12% 299
2024
Q1 		$933K Buy
6,768
+312
+5% +$42.6K 0.15% 274
2023
Q4 		$851K Buy
6,456
+225
+4% +$25.9K 0.16% 261
2023
Q3 		$701K Sell
6,231
-9,302
-60% -$980K 0.16% 275
2023
Q2 		$1.46M Buy
15,533
+138
+0.9% +$13.5K 0.33% 106
2023
Q1 		$1.56M Buy
15,395
+371
+2% +$38.6K 0.39% 88
2022
Q4 		$1.79M Buy
+15,024
New +$1.76M 0.51% 48

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Linden Thomas Advisory Services's NBIX Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Neurocrine Biosciences (NBIX) stake by 150% in Q2 2026, buying an estimated $1.66M and bringing the position to 18,676 shares worth $3.15M. The position accounts for 0.25% of the portfolio, ranked #115.

Linden Thomas Advisory Services first reported a position in NBIX in Q4 2022 and has held it in 15 quarters since. 166 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Linden Thomas Advisory Services held 18,676 shares of Neurocrine Biosciences worth $3.15M as of Q2 2026.
  • Linden Thomas Advisory Services bought 11,215 Neurocrine Biosciences shares in Q2 2026, an estimated $1.66M.
  • Neurocrine Biosciences made up 0.25% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #115 holding.
  • Linden Thomas Advisory Services first reported a position in Neurocrine Biosciences in Q4 2022 and has held it in 15 quarters since.
  • 166 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.